Pioneering BRCA1/2 Point-Of-Care Testing for Integration of Germline and Tumor Genetics in Breast Cancer Risk Management: A Vision for the Future of Translational Pharmacogenomics

Research performed in South African (SA) breast, ovarian and prostate cancer patients resulted in the development of a rapid BRCA point-of-care (POC) assay designed as a time- and cost-effective alternative to laboratory-based technologies currently used for first-tier germline DNA testing. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Mampunye, Lwando, van der Merwe, Nerina C., Grant, Kathleen A., Peeters, Armand V., Torrorey-Sawe, Rispah, French, David J., Moremi, Kelebogile E., Kidd, Martin, van Eeden, Petrus C., Pienaar, Fredrieka M., Kotze, Maritha J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513538/
https://www.ncbi.nlm.nih.gov/pubmed/34660253
http://dx.doi.org/10.3389/fonc.2021.619817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513538/
https://www.ncbi.nlm.nih.gov/pubmed/34660253
http://dx.doi.org/10.3389/fonc.2021.619817

Ejemplares similares